Encorafenib Market Introduction:
The kinase inhibitor Encorafenib is used to treat melanoma among other malignancies. It functions by concentrating on certain genetic alterations that fuel the development of cancer. Array BioPharma, a division of Pfizer, created encorafenib, a specific inhibitor of BRAF kinase? Specifically, it was made to block the mutant BRAF V600E/K proteins, which...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian